BACKGROUND: The prognostic value of non-obstructive, CT low-dense plaques (CTLDP) on multislice computed tomography (MSCT) for the prediction of nonfatal acute myocardial infarction (AMI), unstable angina (UA) and cardiac death has not yet been defined. METHODS AND RESULTS: In the present study 810 patients who underwent MSCT and had non-obstructive coronary artery disease were followed up for the occurrence of AMI, UA and cardiac death. Non-obstructive CTLDP were defined as plaques with a CT density <68 Hounsfield units, accompanied by mild to moderate coronary artery stenosis (25-75%). Patients were followed-up for 1,062+/-544 days for the occurrence of (1) acute coronary syndrome (ACS) including nonfatal AMI and UA, and (2) cardiac death. CTLDP were detected in 189 patients (23.3%). The annual event rate of AMI, UA, ACS and cardiac death was 0.91%, 0.91%, 1.82% and 0.36%, respectively, in patients with CTLDP and 0.10%, 0.55%, 0.66% and 0.21%, respectively, in patients without CTLDP. The event rate of ACS was significantly higher in patients with CTLDP than in those without CTLDP (p<0.001). Multivariate Cox proportional regression analysis revealed that previous MI and the presence of CTLDP were independent predictors of ACS. CONCLUSION: Non-obstructive CTLDP detected by MSCT yield prognostic information toward the identification of ACS.
BACKGROUND: The prognostic value of non-obstructive, CT low-dense plaques (CTLDP) on multislice computed tomography (MSCT) for the prediction of nonfatal acute myocardial infarction (AMI), unstable angina (UA) and cardiac death has not yet been defined. METHODS AND RESULTS: In the present study 810 patients who underwent MSCT and had non-obstructive coronary artery disease were followed up for the occurrence of AMI, UA and cardiac death. Non-obstructive CTLDP were defined as plaques with a CT density <68 Hounsfield units, accompanied by mild to moderate coronary artery stenosis (25-75%). Patients were followed-up for 1,062+/-544 days for the occurrence of (1) acute coronary syndrome (ACS) including nonfatal AMI and UA, and (2) cardiac death. CTLDP were detected in 189 patients (23.3%). The annual event rate of AMI, UA, ACS and cardiac death was 0.91%, 0.91%, 1.82% and 0.36%, respectively, in patients with CTLDP and 0.10%, 0.55%, 0.66% and 0.21%, respectively, in patients without CTLDP. The event rate of ACS was significantly higher in patients with CTLDP than in those without CTLDP (p<0.001). Multivariate Cox proportional regression analysis revealed that previous MI and the presence of CTLDP were independent predictors of ACS. CONCLUSION: Non-obstructive CTLDP detected by MSCT yield prognostic information toward the identification of ACS.
Authors: Lorenzo Hernando; Cecilia Corros; Nieves Gonzalo; Rosana Hernández-Antolin; Camino Bañuelos; Pilar Jiménez-Quevedo; Esther Bernardo; Antonio Fernández-Ortiz; Javier Escaned; Carlos Macaya; Fernando Alfonso Journal: Int J Cardiovasc Imaging Date: 2012-04-21 Impact factor: 2.357
Authors: Ilan Gottlieb; Julie M Miller; Armin Arbab-Zadeh; Marc Dewey; Melvin E Clouse; Leonardo Sara; Hiroyuki Niinuma; David E Bush; Narinder Paul; Andrea L Vavere; John Texter; Jeffery Brinker; João A C Lima; Carlos E Rochitte Journal: J Am Coll Cardiol Date: 2010-02-16 Impact factor: 24.094
Authors: Tomasz Miszalski-Jamka; Piotr Klimeczek; Robert Banyś; Maciej Krupiński; Krzysztof Nycz; Krzysztof Bury; Michał Lada; Robert Pelberg; Dean Kereiakes; Wojciech Mazur Journal: Int J Cardiovasc Imaging Date: 2011-03-03 Impact factor: 2.357
Authors: E Maffei; K Nieman; C Martini; O Catalano; S Seitun; T Arcadi; R Malagò; A Rossi; A Clemente; N R Mollet; F Cademartiri Journal: Radiol Med Date: 2011-11-17 Impact factor: 3.469